nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach
|
Marchetti, Paolo |
|
2016 |
91 |
C |
p. 50-63 14 p. |
artikel |
2 |
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent manner
|
Rephaeli, Ada |
|
2016 |
91 |
C |
p. 91-97 7 p. |
artikel |
3 |
Bioactive glass nanoparticles designed for multiple deliveries of lithium ions and drugs: Curative and restorative bone treatment
|
El-Kady, Abeer M. |
|
2016 |
91 |
C |
p. 243-250 8 p. |
artikel |
4 |
Calendar of Events
|
|
|
2016 |
91 |
C |
p. VIII- 1 p. |
artikel |
5 |
Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant
|
Bu, Pengli |
|
2016 |
91 |
C |
p. 162-171 10 p. |
artikel |
6 |
Development of hematin conjugated PLGA nanoparticle for selective cancer targeting
|
Amin, Md. Lutful |
|
2016 |
91 |
C |
p. 138-143 6 p. |
artikel |
7 |
Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations
|
Horkovics-Kovats, Stefan |
|
2016 |
91 |
C |
p. 265-277 13 p. |
artikel |
8 |
Dual functioning microspheres embedded crosslinked gelatin cryogels for therapeutic intervention in osteomyelitis and associated bone loss
|
Pandey, Gitu |
|
2016 |
91 |
C |
p. 105-113 9 p. |
artikel |
9 |
Editorial board members
|
|
|
2016 |
91 |
C |
p. IFC- 1 p. |
artikel |
10 |
Effectiveness of supersaturation promoting excipients on albendazole concentrations in upper gastrointestinal lumen of fasted healthy adults
|
Kourentas, Alexandros |
|
2016 |
91 |
C |
p. 11-19 9 p. |
artikel |
11 |
Effects of cyclodextrins on the structure of LDL and its susceptibility to copper-induced oxidation
|
Ao, Meiying |
|
2016 |
91 |
C |
p. 183-189 7 p. |
artikel |
12 |
Efficacy assessment of local doxycycline treatment in periodontal patients using multivariate chemometric approach
|
Bogdanovska, Liljana |
|
2016 |
91 |
C |
p. 114-121 8 p. |
artikel |
13 |
Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery
|
Song, Su Jeong |
|
2016 |
91 |
C |
p. 20-30 11 p. |
artikel |
14 |
Evaluation of the artificial membrane permeability of drugs by digital simulation
|
Nakamura, Mayumi |
|
2016 |
91 |
C |
p. 154-161 8 p. |
artikel |
15 |
Formulation and stabilization of norfloxacin in liposomal preparations
|
Ahmad, Iqbal |
|
2016 |
91 |
C |
p. 208-215 8 p. |
artikel |
16 |
Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates
|
Damont, Annelaure |
|
2016 |
91 |
C |
p. 98-104 7 p. |
artikel |
17 |
Impact of anti-PEG IgM antibodies on the pharmacokinetics of pegylated asparaginase preparations in mice
|
Poppenborg, Sabine M. |
|
2016 |
91 |
C |
p. 122-130 9 p. |
artikel |
18 |
Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin
|
Yankovsky, Igor |
|
2016 |
91 |
C |
p. 172-182 11 p. |
artikel |
19 |
Indoles — A promising scaffold for drug development
|
Sravanthi, T.V. |
|
2016 |
91 |
C |
p. 1-10 10 p. |
artikel |
20 |
Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations
|
Jafari, Samira |
|
2016 |
91 |
C |
p. 225-235 11 p. |
artikel |
21 |
Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration
|
Shah, Brijesh |
|
2016 |
91 |
C |
p. 196-207 12 p. |
artikel |
22 |
PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility
|
Muhammad, Zarmina |
|
2016 |
91 |
C |
p. 251-255 5 p. |
artikel |
23 |
Position Paper: EUFEPS Network on Veterinary Medicines Initiative
|
|
|
2016 |
91 |
C |
p. I-VII nvt p. |
artikel |
24 |
Preclinical efficacy of a gastro-sparing novel thiazolidin-4-one in alleviating secondary lesions of polyarthritis: A multi-parametric approach
|
Mudgal, Jayesh |
|
2016 |
91 |
C |
p. 74-83 10 p. |
artikel |
25 |
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
|
Maina, Theodosia |
|
2016 |
91 |
C |
p. 236-242 7 p. |
artikel |
26 |
Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin
|
Yao, Yashu |
|
2016 |
91 |
C |
p. 144-153 10 p. |
artikel |
27 |
Regenerated cellulose capsules for controlled drug delivery: Part III. Developing a fabrication method and evaluating extemporaneous utility for controlled-release
|
Bhatt, Bhavik |
|
2016 |
91 |
C |
p. 40-49 10 p. |
artikel |
28 |
Study of the effect of mixing approach on cross-linking efficiency of hyaluronic acid-based hydrogel cross-linked with 1,4-butanediol diglycidyl ether
|
Al-Sibani, Mohammed |
|
2016 |
91 |
C |
p. 131-137 7 p. |
artikel |
29 |
Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors
|
Madsen, Cecilie Maria |
|
2016 |
91 |
C |
p. 31-39 9 p. |
artikel |
30 |
The development of a peak-time criterion for designing controlled-release devices
|
Simon, Laurent |
|
2016 |
91 |
C |
p. 64-73 10 p. |
artikel |
31 |
The effect of hyperlipidemia on the pharmacokinetics, hepatic and pulmonary uptake of posaconazole in rat
|
Khalil, Hadeel A. |
|
2016 |
91 |
C |
p. 190-195 6 p. |
artikel |
32 |
Topical delivery of a Rho-kinase inhibitor to the cornea via mucoadhesive film
|
Chan, Wendy |
|
2016 |
91 |
C |
p. 256-264 9 p. |
artikel |
33 |
Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: A new treatment strategy
|
Ramadass, Satiesh Kumar |
|
2016 |
91 |
C |
p. 216-224 9 p. |
artikel |
34 |
Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
|
Flanagan, Talia |
|
2016 |
91 |
C |
p. 84-90 7 p. |
artikel |